C-Myc (hereafter, Myc) is a cancer driver whose abundance is regulated by the SCF Fbw7 ubiquitin ligase and proteasomal degradation. Fbw7 binds to a phosphorylated Myc degron centered at threonine 58 (T58), and mutations of Fbw7 or T58 impair Myc degradation in cancers. Here, we identify a second Fbw7 phosphodegron at Myc T244 that is required for Myc ubiquitylation and acts in concert with T58 to engage Fbw7. While Ras-dependent Myc serine 62 phosphorylation (pS62) is thought to stabilize Myc by preventing Fbw7 binding, we find instead that pS62 greatly enhances Fbw7 binding and is an integral part of a high-affinity degron. Crystallographic studies revealed that both degrons bind Fbw7 in their diphosphorylated forms and that the T244 degron is recognized via a unique mode involving Fbw7 arginine 689 (R689), a mutational hotspot in cancers. These insights have important implications for Myc-associated tumorigenesis and therapeutic strategies targeting Myc stability.
22 October 2020 in Proceedings of the National Academy of Sciences
Significance: HPV+ HNSCC is a growing problem in the United States. We show that HPV16 E6/E7 render HNSCC sensitive to WEE1 inhibition through a CDK1-FOXM1 circuit that drives premature mitosis and requires E6 activities beyond p53 inactivation. Primary HPV+ HNSCCs exhibit high FOXM1 activity, which may underlie their sensitivity to WEE1 inhibition. These data provide a mechanistic rationale for WEE1i incorporation into HPV+ HNSCC treatment.